Study Details

General Information

Sanofi Pasteur Vaccine MET42

'Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers'

ProtocolMET42
IdentifierAttn: Roger Masotti
UID60a800b4-b88f-41bb-85db-d957b3d42e53
StatusDone - Archived
Phase3
Category
Launch Year2018
NCT Number-
Created2017-12-18 12:57
Last Updated2017-12-18 12:57

Description

No description provided.

Comment

CRI

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.2018-03-27No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2018-11-06No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalCasaclang, CeciliaCCasaclangNo
RecruiterMiss, SalomonSMissNo
CoordinatorValenzuela, LouisitoLValenzuelaNo
RegulatoryRamirez, ClaudiaCRamirezNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorSanofi Pasteur, Inc.
DivisionSanofi Pasteur
TeamSanofi Pasteur
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CRO
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?